Annovis Bio, Inc. Profile Avatar - Palmy Investing

Annovis Bio, Inc.

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's di…

Biotechnology
US, Berwyn [HQ]

Resulting Ratios

7 Records · Starting from 2017
Loading...
End of ANVS's Analysis
CIK: 1477845 CUSIP: 03615A108 ISIN: US03615A1088 LEI: - UEI: -
Secondary Listings
ANVS has no secondary listings inside our databases.